Taking your genes in hand
By The Economist,
The Economist
| 12. 06. 2007
Personal genetic testing is advancing rapidly. But beware of overselling
GENETIC testing promises a lot. In particular, it promises to tell people things ranging from their risks of developing ailments as diverse as heart disease, cancer and autism to how much coffee they can safely drink. It also promises a lucrative market for those doing the testing. Single-gene tests, such as those for particular forms of genes that predispose people to breast cancer, have been available for a while. This year, however, has seen the arrival of commercial versions of techniques that can sample a person's entire genetic make-up, and do so in a way that will enable him to benefit from future discoveries as well as existing knowledge.
In many cases, knowing the risk will also allow (and might, indeed, encourage) someone to modify his behaviour to avoid a disease he is at risk of—or, failing that, to mitigate its consequences. Nevertheless, concerns are being raised about the accuracy of some tests now on the market, and also their usefulness when the results are supplied direct to consumers, rather...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Dalton Conley, The New York Times | 03.13.2025
Since Francis Galton coined the phrase “nature versus nurture” 150 years ago, the debate about what makes us who we are has dominated the human sciences.
Do genes determine our destiny, as the hereditarians would say? Or do we enter...